EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID-19 Pandemic Impact on Uro-Oncological Disease Outcomes at a German Referral Center

Moustafa Elleisy, Desiree Louise Dräger, Heike Zettl, Oliver W Hakenberg

Urologia Internationalis · 2024

DOI: 10.1159/000541932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Moustafa Elleisy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Medical Center Rostock, Rostock, Germany. Hauptthemen laut MEDLINE: COVID-19, Urologic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To assess differences in referral and pathologic outcomes for uro-oncology cases prior to, during, and after the COVID-19 pandemic, comparing clinical and pathological data from cancer surgeries performed at a university medical center between 2018 and 2023.

Methods

We collected data of 212 patients with radical prostatectomy (RP) for prostate cancer, 157 patients with radical cystectomies (RCs) for bladder cancer, 36 patients with radical nephroureterectomies (RNUs) for upper tract urothelial carcinoma, 133 patients with partial nephrectomies (PNs), and 160 patients with radical nephrectomies (RNs) for renal cancer, 93 patients with orchifunicolectomy for testicular cancer, 39 patients with newly diagnosed penile cancer. Data from patients treated between 2018 and February 2020 (before the COVID-19 pandemic) were compared with data from patients treated between March 2020 and March 2022 (during the COVID-19 pandemic) and between April 2022 and February 2023 (after the COVID-19 pandemic).

Results

No differences in terms of main pathologic features were observed in patients undergoing RP, RNU, orchifunicolectomy, or circumcision and/or penectomy. Further, a lower pathological tumor stage was diagnosed for RN after the COVID-19 pandemic (p < 0.05). A higher age at diagnosis for penile cancer was observed during the pandemic cohort in comparison to the pre-COVID-19 pandemic cohort (p < 0.05), but this did not translate into a worse pathological stage or lymph node involvement. Another notable change was the shortening of the length of stay (LOS) for orchifunicolectomy over the pandemic (p < 0.05).

Conclusion

Neither decline in uro-oncologic activity nor pathological features were observed at our institution before, during, and after the COVID-19 pandemic. A significantly lower pathological tumor stage for RN after the COVID-19 pandemic was seen. Penile cancer was diagnosed at a significantly higher age during the COVID-19 pandemic, and a decrease in LOS for orchifunicolectomy was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Urologic NeoplasmsHumansMaleMiddle AgedAgedGermanyReferral and ConsultationProstatectomyRetrospective StudiesSARS-CoV-2Treatment OutcomeFemale

Stichwörter der Autor:innen

COVID-19CancerDelayPathological outcomesUro-oncology

Autor:innen und Institutionen

  • Department of Urology, University Medical Center Rostock, Rostock, Germany.
  • Clinical Cancer Registry, University Medicine Rostock, Rostock, Germany.

Zitieren

APA

Elleisy, M., Dräger, D. L., Zettl, H., & Hakenberg, O. W. (2024). COVID-19 Pandemic Impact on Uro-Oncological Disease Outcomes at a German Referral Center. Urologia Internationalis. https://doi.org/10.1159/000541932

Vancouver

Elleisy M, Dräger DL, Zettl H, Hakenberg OW. COVID-19 Pandemic Impact on Uro-Oncological Disease Outcomes at a German Referral Center. Urologia Internationalis. 2024. doi:10.1159/000541932

BibTeX
@article{Elleisy2024,
  author = {Elleisy, Moustafa and Dräger, Desiree Louise and Zettl, Heike and Hakenberg, Oliver W},
  title = {COVID-19 Pandemic Impact on Uro-Oncological Disease Outcomes at a German Referral Center},
  journal = {Urologia Internationalis},
  year = {2024},
  doi = {10.1159/000541932}
}
Kostenlos starten →